Bob Brownell
Managing Director @ Emergent Medical Partners
Mountain View, United States
Bob Brownell is a Series A investor at Emergent Medical Partners in Mountain View focused on Medical and Wearables. Bob has a broad range of business development, legal and management experience. With 20 years of counseling life sciences companies from formation to maturity, Bob has a wealth of experience that benefits portfolio companies. Before joining Emergent he was a partner at MedVenture Associates, a medtech venture capital firm. Prior to becoming aventure capitalist, Bob was Vice President and General Counsel of TheraSense, Inc., where he was a key member of the company’s management team. He joined TheraSense while it was still a private company after serving as its outside counsel since its initial incorporation. Bob left TheraSense following its acquisition and integration with Abbott Laboratories. Prior to TheraSense Bob was a corporate and securities partner at Wilson Sonsini Goodrich & Rosati, where he worked for twelve years following law school. His practice focused on the representation of technology companies from their earliest stages with an emphasis on life sciences companies. Bob received his J.D. from UCLA Law School and has a B.A. from the University of California at Berkeley.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Bob Brownell invests in
Stages Bob Brownell invests in
Countries Bob Brownell invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Wearables 1 (100%)
- Health Care 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ReThink Medical is a medical device and digital health company developing a wrist-worn monitoring device. Our technology is designed to predict and prevent heart failure hospitalizations through compliance-centric continuous physiologic monitoring & machine learning. Our product, CorBand™ uses state of the art algorithms and artificialintelligence to potentially detect worsening conditions weeks in advance - even before noticeable symptoms. Data-driven therapy can allow ample time for proper treatment to prevent hospitalization, improve quality of life, and save billions in healthcare costs. We've designed a proactive approach to managing heart failure patients with a focus on compliance, simplicity, and accuracy. | $3.5M / Series A / May 01, 2017 |
Co-Investors
Emergent Medical Partners is a California-based life sciences investment firm focused on medical device and healthcare companies. The firm was founded in 2006 and is headquartered in Portola Valley, California, United States.
Emergent Medical Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Thomas Fogarty
Co-Founder & Managing Director
|
|||
Allan May
Managing Director
|
|||
|
Bob Brownell
Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bob Brownell invest in?
Bob Brownell invests primarily in Medical, Wearables and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bob Brownell?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Bob Brownell last invest?
The most recent investment recorded for Bob Brownell closed in May 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
